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General Information.  NMR spectra were recorded on an Oxford 300 MHz NMR spectrometer
running Varian VNMR software.  Chemical shifts are reported in parts per million (ppm)
downfield from tetramethylsilane (TMS) with reference to internal solvent for 1H NMR and 13C
NMR spectra.  Chemical shifts are reported in parts per million (ppm) downfield from H3PO4 for
31P NMR spectra.  Multiplicities are abbreviated as follows: singlet (s), doublet (d), triplet (t),
quartet (q), quintet (quint), septet (sept), multiplet (m), and broad (br).  Optical rotations were
taken on a Jasco P-1010 polarimeter with a wavelength of 589 nm.  The concentration “c” has
units of g/100mL (or 10 mg/mL) unless otherwise noted.  Analytical thin-layer chromatography
(TLC) was performed using silica gel 60 F254 precoated plates (0.25 mm thickness) with a
fluorescent indicator.  Visualization was performed with standard potassium permanganate stains
or UV light.  Flash column chromatography of organic compounds was performed using silica
gel 60 (230-400 mesh), and flash column chromatography of ruthenium compounds was
performed using silica gel 60 (230-400 mesh) from TSI Scientific (Cambridge, MA).  All
enantiomeric purities were determined by chiral GC (Chiraldex G-TA, 30m×0.25mm or CP
Chirasil-Dex-CB, 25m×0.25mm) and were compared to racemic samples.  All glassware was
either oven dried or flame dried, and reactions were done under an atmosphere of argon unless
otherwise noted.  All organic solvents were dried by passage through solvent purification
columns containing activated alumina.  All commercial chemicals were used as obtained, and
(PCy3)2Ru(=CHPh)Cl2 (31) was a gift from Materia, Inc.  Compounds 25, 26i, 27, and 28ii are
known compounds.
                                                 
i Zhu, S. S.; Cefalo, D. R.; La, D. S.; Jamieson, J. Y.; Davis, W. M.; Hoveyda, A. H.; Schrock, R.
R. J. Am. Chem. Soc. 1999, 121, 8251–8259.
ii Kiely, A. F.; Jernelius, J. A.; Schrock, R. R.; Hoveyda, A. H. J. Am. Chem. Soc. 2002, 124,
2868–2869.
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2-Bromo-1,4-diisopropylbenzene as a mixture (7b).  Following a known procedure,iii to 1,4-
diisopropylbenzene (10 ml, 53 mmol) and Fe (250 mg, 4.5 mmol) in CH2Cl2 (10 ml) at 0 °C was
added by syringe over 15 min Br2 (2.67 ml, 52 mmol) in CH2Cl2 (10 ml).  The red solution was
warmed to rt and stirred for 7 days.  The reaction was filtered and washed with Na2SO3 until it
was colorless, and was dried over MgSO4 and concentrated.  The oil was purified by column
chromatography (100% pentane) to yield 11.35 g (86% yield by weight) of 7b, which was a 4:1
mixture of brominated products and starting material.
OH OH OH
Br
OMe
Br
t-BuOH
conc. H2SO4
CH2Cl2
0 °C to rt, 24 h
Br2
CHCl3, 65 °C, 5 min
MeI
K2CO3
acetone
40 °C, 12 h
7c
1-Bromo-5-tert-butyl-2-isopropyl-4-methoxybenzene (7c).  To a solution of 3-isopropyl
phenol (10g, 73 mmol) in CH2Cl2 at 0 °C was added tert-butyl alcohol (7.0 ml, 73 mmol) and
conc. H2SO4 (3.9 ml, 73 mmol).  The reaction was allowed to warm to rt and stirred for 24 h.  It
was quenched with NaHCO3 and the organic layer was removed. The aqueous layer was
extracted 3× with CH2Cl2 and the combined organic fractions were dried over MgSO4,
concentrated, and purified by column chromatography (5% EtOAc in hexanes) to yield 12.2 g
(87%) of the alkylated phenol. 1H NMR (300 MHz, CDCl3, ppm): δ 7.20 (d, J = 8.1 Hz, 1H),
6.76 (dd, J = 8.1, 1.8 Hz, 1H), 6.54 (d, J = 1.8 Hz, 1H), 4.71 (s, 1H), 2.83 (sept, J = 6.9 Hz, 1H),
1.41 (s, 9H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (75 MHz, CDCl3, ppm): δ 154.2, 148.2, 133.6,
                                                 
iii Patel, B. A.; Ziegler, C. B.; Cortese, N. A.; Plevyak, J. E.; Zebovitz, T. C.; Terpko, M.; Heck,
R. F. J. Org. Chem. 1977, 42, 3903–3907.
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127.1, 118.7, 114.9, 34.4, 33.5, 29.9, 24.1.  HRMS (EI+) m/z calc for C13H20O: 192.1514, found
192.1511.  Br2 (980 µl, 19 mmol) in CHCl3 (8 ml) was added dropwise over 20 min from an
addition funnel to the alkylated phenol (3.5 g, 19 mmol) in CHCl3 (35 ml) stirring at 65 °C.  The
reaction stirred for 5 min and was quenched with sat’d Na2S2O3 (aq). The organic layer was
removed and the aqueous layer was extracted 3× with CHCl3, and the combined organic fractions
were dried over MgSO4, concentrated, and purified by column chromatography (5% EtOAc in
hexanes) to yield 3.6 g (74%) of the brominated phenol. 1H NMR (300 MHz, CDCl3, ppm): δ
7.36 (s, 1H), 6.58 (s, 1H), 4.80 (s, 1H), 3.24 (sept, J = 6.9 Hz, 1H), 1.38 (s, 9H), 1.20 (d, J = 6.9
Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 153.9, 146.0, 135.9, 131.3, 115.0, 114.8, 34.6,
32.7, 29.7, 23.0.  HRMS (EI+) m/z calc for C13H19OBr: 270.0619, found 270.0617.  To a
suspension of the brominated phenol (3.55 g, 13 mmol) and K2CO3 (5.39 g, 39 mmol) in acetone
(100 ml) was added MeI (2.45 ml, 39 mmol).  The reaction was heated to 40 °C and stirred for
12 h.  It was cooled to rt, filtered through a glass frit, and washed with acetone.  The filtrate was
concentrated and purified by column chromatography (5% EtOAc in hexanes) to yield 2.93 g
(79%) of 7c. 1H NMR (300 MHz, CDCl3, ppm): δ 7.36 (s, 1H), 6.76 (s, 1H), 3.83 (s, 3H), 3.30
(sept, J = 6.9 Hz, 1H), 1.34 (s, 9H), 1.24 (d, J = 6.9 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm):
δ 158.3, 145.7, 138.1, 130.8, 114.7, 110.1, 55.4, 34.8, 33.1, 29.8, 23.1.  HRMS (EI+) m/z calc for
C14H21OBr: 284.0776, found 284.0762.
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1-Bromo-2,3-diisopropylbenzene (7d).  To a solution of 2-isopropylbromobenzene (purchased
from Lancaster) (8.6 ml, 56 mmol) in Et2O (100 ml) at 0 °C was added nBuLi (1.4 M in Et2O, 42
mL, 59 mmol) and the reaction stirred for 5h at 0 °C.  The reaction was cooled to –78 °C and
acetone (41 ml, 560 mmol) was added in one portion.  The reaction was allowed to warm to rt as
it stirred for 12h and was quenched with H2O.  The organic layer was removed, washed with
sat’d NaCl (aq), dried over MgSO4 and purified by column chromatography (7% EtOAc in
pentane) to give 8.82 g (88%) of the desired aromatic alcohol as a white solid.  On a larger scale
(25 g of 2-isopropylbromobenzene), instead of purifying by column chromatography, the
concentrated solution sat at rt for 48h and 13.22 g (59%) of the desired product crystallized.   1H
NMR (300 MHz, CDCl3, ppm): δ 7.45-7.38 (m, 2H), 7.29-7.24 (m, 1H), 7.16-7.11 (m, 1H), 3.91
(sept, J = 6.9 Hz, 1H), 1.79 (br s, 1H), 1.70 (s, 6H), 1.27 (d, J = 6.9 Hz, 6H). 13C NMR (75 MHz,
CDCl3, ppm): δ 148.3, 144.5, 128.0, 127.7, 125.5, 125.1, 73.8, 32.0, 29.5, 25.0.  HRMS (EI+)
m/z calc for C12H18O: 178.1350, found 178.1358.  This procedure was based on a literature
precedent.iv  This reaction has given variable yields 12% - 25%; what follows is the procedure
for the reaction that gave 25% yield.  To a solution of the aromatic alcohol (600 mg, 3.4 mmol)
and TMEDA (2 ml, 13 mmol) in Et2O (23 ml) at 0 °C was added nBuLi (1.3 M in Et2O, 10 mL,
                                                 
iv Taber, D. F.; Dunn, B. S.; Mack, J. F.; Saleh, S. A. J. Org. Chem. 1985, 50, 1987–1988.
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13 mmol).  The reaction warmed to rt over 15 min and a reflux condenser was attached, and it
was heated to 32 °C for 4h.  The reaction was cooled to –78 °C, and 1,2-dibromoethane (1.5 ml,
17 mmol) was added.  The reaction was allowed to warm to rt as it stirred for 12h.  It was
quenched with H2O, washed with NaCl (aq), dried over Na2SO4, and purified by column
chromatography (7% EtOAc in pentane) to give 214 mg (25%) of the brominated aromatic
alcohol and 232 mg (39%) of unreacted starting material.  1H NMR (300 MHz, CDCl3, ppm): δ
7.40 (dd, J = 7.8, 1.5 Hz, 1H), 7.31 (dd, J = 7.8, 1.5 Hz, 1H), 7.00 (t, J = 7.8 Hz, 1H), 4.03 (sept,
J = 6.9 Hz, 1H), 1.87 (s, 6H), 1.22 (d, J = 6.9 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ
151.9, 144.2, 133.2, 127.8, 127.5, 120.2, 76.3, 32.3, 31.4, 25.4.  HRMS (EI+) m/z calc for
C12H17OBr: 256.0470, found 256.0463.  This procedure was based on a literature precedent.v
TMSCl (1.5 ml, 11 mmol), NaI (1.7 g, 11 mmol), and CH3CN (300 µl) were prestirred for 30
min at rt, and the brominated aromatic alcohol (500 mg, 1.9 mmol) was added as a solution in
pentane (5 ml) and CH3CN (200 µl).  The reaction stirred for 5h at rt, and Et2O and H2O were
added to the reaction mixture.  The organic layer was removed, dried over MgSO4, concentrated,
and the residue was passed through a small plug of silica gel with Et2O to give 439 mg (96%) of
the bromostyrene as an orange oil. 1H NMR (300 MHz, CDCl3, ppm): δ 7.40 (dd, J = 7.8, 1.5 Hz,
1H), 7.24 (dd, J = 7.8, 1.5 Hz, 1H), 7.10 (t, J = 7.8 Hz, 1H), 5.32-5.30 (m, 1H), 4.84-4.83 (m,
1H), 3.13 (sept, J = 6.9 Hz, 1H), 2.02 (t, J = 1.5 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H), 1.16 (d, J =
5.4 Hz, 3H). 13C NMR (75 MHz, CDCl3, ppm): δ 130.0, 128.6, 124.7, 116.4, 31.0, 25.3, 24.4,
24.2.  HRMS (EI+) m/z calc for C12H15Br: 238.0353, found 238.0357.  A solution of the
bromostyrene (2.0 g, 8.4 mmol) and (R)-[Ir(Ph2; iPr-PHOX)(COD)]BArFvi (1.3 g, 0.84 mmol) in
CH2Cl2 (20 ml) was placed in a stainless steel pressure bomb.  The bomb was pressurized and
                                                 
v Sakai, T.; Miyata, K.; Utaka, M.; Takeda, A. Tet. Lett. 1987, 28, 3817–3818.
vi a) Pfaltz, P.; Blankenstein, J.; Hörmann, E.; McIntyre, S.; Menges, F.; Hilgraf, R.; Schönleber,
M.; Smidt, S. P.; Wüstenberg, B.; Zimmermann, N. Adv. Synth. Catal. 2003, 345, 33–43.  b)
Lightfoot, A.; Schnider, P.; Pfaltz, A. Angew. Chem. Int. Ed. Engl. 1998, 37, 2897–2899.
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vented with 3×500 psi H2 and was sealed at 500 psi H2.  The reaction stirred at rt for 24h and was
vented, concentrated, and passed through a short silica gel plug (100% pentane) to yield 1.73 g
(87%) of 7d as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm) δ 7.39 (dd, J = 7.8, 1.5 Hz,
1H), 7.23-7.21 (dd, J = 7.8, 1.5 Hz, 1H), 6.99 (t, J = 7.8 Hz, 1H), 3.93-3.28 (m, 2H), 1.47 (br s,
2H), 1.36 (d, J = 6.9 Hz, 4H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (75 MHz, CDCl3, ppm): δ
130.8, 127.6, 127.0, 34.1, 29.8, 24.9, 24.3, 21.9, 20.4.  HRMS (EI+) m/z calc for C12H17Br:
240.0524, found 240.0514.
General 2-Step Procedure for Chiral 4,5-Dihydroimidazolium Salts.  A solution of the aryl
bromide (2.2 equiv) in toluene in a sealable schlenk tube was freeze/pump/thawed 3 times.  After
reaching rt, the positive argon pressure was briefly stopped and to this solution was added
(1R,2R)-(+)-1,2-diphenylethylenediamine (1 equiv), Pd2(dba)3•CHCl3 (0.05 equiv), and (±)-
BINAP (0.12 equiv) in one portion.  The argon pressure was immediately resumed, and a very
brief pump/backfill was performed at rt.  NaOt-Bu (3 equiv) was added and the reaction was
heated to 90 °C and sealed.  The reaction mixture stirred for 48 h at 90 °C, and after cooling to rt
was quickly passed through a small silica gel column with 5% EtOAc in hexanes.  The eluting
was stopped when no more UV active material came off the column.  The eluent containing
partially purified diaryl diamine (8) was concentrated and (EtO)3CH was added.  To this solution
was added NH4BF4 (1 equiv) and 2 drops of formic acid.  The reaction was heated to 120 °C and
stirred for 12 h.  Upon cooling to rt, Et2O was added and a white precipitate was briefly
observed, but ultimately a thick oil formed.  Thus, the reaction was concentrated, purified by
flash chromatography (MeOH in CH2Cl2), and placed under high vacuum for 12 h to yield the
desired 4,5-dihydroimidazolium salt (9) as a hard foam.
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(4R,5R)-1,3-Bis-(2-isopropylphenyl)-4,5-diphenyl-4,5-dihydro-3H-imidazol-1-ium
tetrafluoroborate (9a).  Using the general procedure above, 2-isopropylbromobenzene (7a)
(0.55 mL, 3.5 mmol), (1R,2R)-(+)-1,2-diphenylethylenediamine (351 mg, 1.6 mmol),
Pd2(dba)3•CHCl3 (83 mg, 0.08 mmol), (±)-BINAP (118 mg, 0.19 mmol), and NaOt-Bu (461 mg,
4.8 mmol) in 5 mL toluene gave crude 8a, which was used directly in the next step.  Assuming
100% yield in the coupling, 8a, (EtO)3CH (2.7 mL, 16 mmol), NH4BF4 (168 mg, 1.6 mmol), and
2 drops of formic acid gave crude product that was purified by 5% MeOH in CH2Cl2 to give 336
mg (38% over 2 steps) of 9a as a hard foam.  Spectral data matched that previously reported (c
values for optical rotations in this reference are in g/10 mL).vii
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(4R,5R)-1,3-Bis-(5-tert-butyl-2-isopropyl-4-methoxyphenyl)-4,5-diphenyl-4,5-dihydro-3H-
imidazol-1-ium tetrafluoroborate (9c).  Using the general procedure above, 7c (1.0 g, 3.5
mmol), (1R,2R)-(+)-1,2-diphenylethylenediamine (351 mg, 1.6 mmol), Pd2(dba)3•CHCl3 (83 mg,
0.08 mmol), (±)-BINAP (118 mg, 0.19 mmol), and NaOt-Bu (461 mg, 4.8 mmol) in 3.5 mL
                                                 
vii Seiders, J. T.; Ward, D. W.; Grubbs, R. H. Org. Lett. 2001, 3, 3225–3228.
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toluene gave crude 8c, which was used directly in the next step.  Assuming 100% yield in the
coupling, 8c, (EtO)3CH (2.7 mL, 16 mmol), NH4BF4 (168 mg, 1.6 mmol), and 2 drops of formic
acid gave crude product that was purified by 10% MeOH in CH2Cl2 to yield a viscous yellow oil.
This oil is the desired salt by 1H NMR, but further purification gives better yields in the catalyst
preparation step.  Further purification consists of dissolving the yellow oil in copious Et2O (100
ml) and letting the solution sit at rt for 12 h.  At this time, a white precipitate was observed, the
rest of the ether was decanted off, the precipitate was washed with a minimal amount of ether
and dried to yield 614 mg (53% over 2 steps) of 9c.  The remaining ether can be concentrated to
give additional material that can also be used to make catalyst but in a reduced yield.  [α]D22 =
+191.31 (c 0.53, CH2Cl2). 1H NMR (300 MHz, CDCl3, ppm): δ 8.21 (s, 1H), 7.43-7.39 (m, 10H),
7.18 (s, 2H), 6.66 (s, 2H), 5.64 (s, 2H), 3.81 (s, 6H), 3.11 (sept, J = 7.2 Hz, 2H), 1.36 (d, J = 6.6
Hz, 12H), 1.24 (s, 18H). 13C NMR (75 MHz, CDCl3, ppm): δ 161.1, 160.0, 157.6, 151.1, 143.7,
138.0, 133.7, 130.6, 129.9, 129.0, 127.0, 123.2, 108.8, 55.3, 34.9, 29.5, 29.0, 25.0, 24.3. HRMS
(FAB+) m/z calc for C43H55N2O2; 631.4264, found 631.4280.
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(4R,5R)-1,3-Bis-(2,3-diisopropylphenyl)-4,5-diphenyl-4,5-dihydro-3H-imidazol-1-ium
tetrafluoroborate (9d).  Using the general procedure above, 7d (788 mg, 3.3 mmol), (1R,2R)-
(+)-1,2-diphenylethylenediamine (327 mg, 1.5 mmol), Pd2(dba)3•CHCl3 (78 mg, 0.075 mmol),
(±)-BINAP (112 mg, 0.18 mmol), and NaOt-Bu (432 mg, 4.5 mmol) in 4 mL toluene gave 444
mg 8d (21%).  8d (444 mg, 0.83 mmol), (EtO)3CH (2.0 mL, 12 mmol), NH4BF4 (84 mg, 0.83
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mmol), and 2 drops of formic acid gave crude product that was purified by 10% MeOH in
CH2Cl2 to give 333 mg (66%) of 9d as a hard foam.  [α]D22 =  +209.3 (c 0.82, CH2Cl2). 1H NMR
(300 MHz, CDCl3, ppm): δ 8.12 (br s, 1H), 7.41-7.23 (m, 16H), 5.74 (br s, 2H), 3.36-3.33 (m,
4H), 1.63 (s, 6H), 1.47 (br s, 6H), 1.25-1.18 (m, 12H). 13C NMR (75 MHz, CDCl3, ppm): δ
150.1, 140.6, 130.6, 130.2, 130.0, 129.0, 128.2, 29.6, 29.0, 24.8, 24.5, 22.9, 22.6.  HRMS
(FAB+) m/z calc for C39H47N2; 543.3748, found 543.3739.
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(4R,5R)-1,3-Bis-(2,5-diisopropylphenyl)-4,5-diphenyl-4,5-dihydro-3H-imidazol-1-ium
tetrafluoroborate (9b).  This is a three step procedure with stable, isolated intermediates.  The
first and third steps following the general procedure above.  A solution of 7b (1.58 g, 6.6 mmol)
in 5 mL toluene in a sealable schlenk tube was freeze/pump/thawed 3 times and warmed to RT.
To this solution was added (1R,2R)-(+)-1,2-diphenylethylenediamine (500 mg, 2.3 mmol),
Pd2(dba)3•CHCl3 (122 mg, 0.12 mmol), and (±)-BINAP (220 mg, 0.36 mmol) in one portion.
NaOt-Bu (680 mg, 7.1 mmol) was added and the reaction was heated to 90 °C and sealed.  It
stirred for 48 h and after cooling to rt it was quickly passed through a small silica gel column
with 5% EtOAc in hexanes.  The eluting was stopped when no more UV active material came off
of the column.  The eluent was concentrated, and 765 mg of the crude product was isolated as a
mixture of mono- and dibrominated arenes.  PdCl2(dppf)•CH2Cl2 (7.7 mg, 0.0094 mmol) was
added to the crude product (576 mg), and the flask was flushed with argon. To this mixture was
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added degassed DMF (2.5 ml) and Et3N (394 µl, 2.8 mmol).  The reaction was heated to 80 °C
and formic acid (62 µl, 1.7 mmol) was added.  It stirred for 3 h at 80 °C, and 10 ml of a 1:1
solution of Hex/Et2O was added.  The reaction was washed with 1N HCl (aq), sat’d NaHCO3
(aq), and sat’d NaCl (aq).  The organic layer was dried over Na2SO4 and purified by flash
chromatography (6:1 pentane in CH2Cl2) to give 430 mg of the desired diamine (8b).  To 8b
(1.32 g, 2.5 mmol) was added (EtO)3CH (4.1 ml, 25 mmol), NH4BF4 (260 mg, 2.5 mmol) and 2
drops of formic acid.  The reaction was heated to 120 °C and stirred for 12 h.  It was cooled to rt,
Et2O was added, and a yellow solid precipitated.  The solid was purified by flash
chromatography (10% MeOH in CH2Cl2) to yield 1.35 g (86%) of 9b. [α]22D +270.78 (c 0.51,
CH2Cl2). 1H NMR (300 MHz, CDCl3, ppm): δ 8.11 (s, 1H), 7.48-7.19 (m, 16H), 5.83 (s, 2H),
3.11 (sept, J = 6.9 Hz, 2H), 2.82 (sept, J = 6.9 Hz, 2H), 1.31 (d, J = 6.9 Hz, 6H), 1.18 (d, J = 6.6
Hz, 6H), 1.13-1.09 (m, 12H). 13C NMR (75 MHz, CDCl3, ppm): δ 157.0, 148.9, 142.0, 132.9,
130.9, 130.6, 129.8, 129.1, 126.8, 126.6, 77.1, 33.6, 28.6, 24.9, 24.3, 23.8, 23.5.  HRMS (FAB+)
m/z calc for C39H47N2; 543.3739, found 543.3755.
General Procedure for the Synthesis of Chiral Ruthenium Catalysts 2a–5a.  In a drybox,
potassium hexafluoro-t-butoxide, imidazolium salt, and (PCy3)2Ru(=CHPh)Cl2 (31) were
suspended in toluene.  The flask was sealed with a septum and heavy parafilm, removed from the
glove box and stirred at 60 °C for 6 hours.  The reaction mixture was concentrated and purified
by flash chromatography using TSI silica gel (see General Information section) to afford the
desired ruthenium catalyst, which was lyophilized from benzene to give a brown powder.
Further purification by additional flash chromatography was occasionally necessary due to
difficulties in separating unreacted 31.  This further purification resulted in diminished yields.
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Ruthenium Compound 2a.  Following the general procedure above, potassium hexafluoro-t-
butoxide (134 mg, 0.61 mmol), 9a (333 mg, 0.61 mmol), and (PCy3)2Ru(=CHPh)Cl2 (31) (334
mg, 0.41 mmol) in 6 mL toluene gave 398 mg of a brown solid (5% Et2O in hexanes) that was a
10:1 ratio of 2a:31.  Purification by a second flash column (5% Et2O in hexanes) using TSI silica
gel followed by lyophilization from benzene afforded 198 mg (32%) of 2a as a brown powder.
Spectral data matched that previously reported.vii
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Ruthenium Compound 3a.  Following the general procedure above, potassium hexafluoro-t-
butoxide (140 mg, 0.64 mmol), 9b (400 mg, 0.64 mmol), and (PCy3)2Ru(=CHPh)Cl2 (31) (261
mg, 0.32 mmol) in 8 mL toluene afforded 294 mg (85%) of 3a (10% Et2O in pentane), which
was lyophilized from benzene to give a brown powder.  1H NMR (300 MHz, C6D6, ppm): δ
19.83 (s, 1H), 8.50 (s, 1H), 7.53-7.48 (m, 5H), 7.05-6.89 (m, 15H), 6.67 (d, J = 8.1 Hz, 1H), 6.48
(d, J = 8.4 Hz, 1H), 5.34 (d, J = 4.8 Hz, 1H), 5.10 (d, J = 4.5 Hz, 1H), 4.25 (sept, J = 6.6 Hz, 1H),
3.96 (br s, 1H), 2.87 (sept, J = 6.6 Hz, 1H), 2.36 (sept, J = 6.6 Hz, 1H), 2.06 (q, J = 10.8 Hz, 5H),
1.80-0.85 (m, 52H). 31P{1H} NMR (121 MHz, C6D6, ppm): δ 25.5 (s). 13C NMR (126 MHz,
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C6D6, ppm) only diagnostic peaks reported: δ 297.7 (br s), 219.1 (d, J = 78.7 Hz). HRMS
(FAB+) m/z calc for C64H85N2PCl2Ru; 1084.487, found 1084.483.
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Ruthenium Compound 4a.  Following the general procedure above, potassium hexafluoro-t-
butoxide (60 mg, 0.27 mmol), 9c (197 mg, 0.27 mmol), and (PCy3)2Ru(=CHPh)Cl2 (31) (150
mg, 0.18 mmol) in 6 mL toluene afforded 159 mg (75%) of 4a (10% Et2O in pentane), which
was lyophilized from benzene to give a brown powder.  1H NMR (300 MHz, C6D6, ppm): δ
19.80 (s, 1H), 8.28 (s, 1H), 7.65 (d, J = 7.2 Hz, 2H), 7.57 (d, J = 7.2 Hz, 2H), 7.38 (s, 2H), 7.16-
7.00 (m, 10H), 6.74 (s, 1H), 6.09 (s, 1H), 5.35 (d, J = 4.8 Hz, 1H), 5.19 (d, J = 4.8 Hz, 1H), 4.49
(sept, J = 6.6 Hz, 1H), 3.83 (sept, J = 6.9 Hz, 1H),  3.32 (s, 3H), 3.16 (s, 3H), 2.24-1.11 (m,
63H). 31P{1H} NMR (121 MHz, C6D6, ppm): δ 25.4 (s). 13C NMR (126 MHz, C6D6, ppm) only
diagnostic peaks reported: δ 296.3 (d, J = 351.0 Hz), 219.9 (d, J = 79.6 Hz). HRMS (FAB+) m/z
calc for C68H93N2PCl2RuO2; 1172.540, found 1172.546.
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Ruthenium Compound 5a.  Following the general procedure above, potassium hexafluoro-t-
butoxide (109 mg, 0.50 mmol), 9d (313 mg, 0.50 mmol), and (PCy3)2Ru(=CHPh)Cl2 (31) (273
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mg, 0.33 mmol) in 6 mL toluene afforded a brown solid (5% Et2O in pentane), which was a 9:1
ratio of 5a:31.  Purification by a second flash column (5% Et2O in pentane) using TSI silica gel
followed by lyophilization from benzene afforded 160 mg (30%) of 5a as a brown powder.  1H
NMR (300 MHz, C6D6, ppm): δ 19.87 (s, 1H), 9.26 (d, J = 6.6 Hz, 1H), 7.75 (d, J = 7.5 Hz, 2H),
7.17-6.89 (m, 16H), 6.39 (d, J = 7.2 Hz, 1H), 6.14 (br s, 1H), 5.28 (d, J = 3.3 Hz, 1H), 4.98 (d, J
= 3.3 Hz, 1H), 4.35 (quint, J = 7.2 Hz, 1H), 4.04 (br s, 1H), 3.41 (quint, J = 6.9 Hz, 1H), 3.11 (br
s, 1H), 2.21-0.39 (m, 57H). 31P{1H} NMR (121 MHz, C6D6, ppm): δ 26.2 (s); HRMS (FAB+)
m/z calc for C64H85N2PCl2Ru; 1084.487, found 1084.489.
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29
(2E,5E)-3,5-Dimethylhepta-2,5-dien-4-ol (29).viii  Titanocene dichloride (444 mg, 1.78 mmol)
was added to a solution of 2-butyne (5.6 mL, 71 mmol) and isobutylmagnesium bromide (2.0 M
in diethyl ether, 33 mL, 66 mmol) in 60 mL Et2O, and the solution stirred at rt for 1 h.  Trans-2-
methyl-2-butenal (5.7 mL, 59 mmol) in 30 mL Et2O was added slowly, and the mixture stirred at
rt for 3 h.  It was quenched with sat’d aqueous NH4Cl (100 mL), filtered through a pad of Celite,
and the organic layer was removed from the filtrate.  The aqueous layer was extracted with ether
(3×75 mL), and the organic layers were combined, washed with brine, dried over MgSO4, and
evaporated to a brown oil.  The oil was purified by flash chromatography (10% EtOAc in
hexanes) to a yellow oil, which was distilled (Kugelrohr, 1 torr, 120 °C) to give 7.20 g (86%) of
29 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.56 (qquint, J = 6.6, 1.4 Hz, 2H),
4.34 (s, 1H), 1.63 (dt, J = 6.9, 1.1 Hz, 6H), 1.47 (t, J = 1.1 Hz, 6H).  13C NMR (75 MHz, CDCl3,
                                                 
viii (a) Garner, C. M.; Prince, M. E. Tetrahedron Lett. 1994, 35, 2463–2464. (b) Sato, F.;
Ishikawa, H.; Sato, M. Tetrahedron Lett. 1981, 22, 85–88.
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ppm): δ 136.1, 120.4, 81.8, 13.3, 12.1.  HRMS (EI) m/z calc. for C9H16O: 140.1201, found
140.1203.
OH Oallyl bromideNaH
THF, reflux
29 11
(2E,5E)-4-(Allyloxy)-3,5-dimethylhepta-2,5-diene (11).  Alcohol 29 (200 mg, 1.43 mmol) was
added dropwise to a suspension of NaH (60% in oil, 114 mg, 2.85 mmol) in 6 mL THF.  After
stirring at reflux for 15 min, the mixture was allowed to cool to rt, and allyl bromide (430 mg,
3.57 mmol) was added.  The mixture stirred at reflux for 4 h, was quenched with sat’d aqueous
NH4Cl (10 mL), and was extracted with ether (3×15 mL).  The organic layers were combined,
dried over MgSO4, and evaporated to an oil which was purified by flash chromatography (1%
EtOAc in hexanes) to give 210 mg (82%) of 11 as a colorless oil.  Spectral data matched that in
the literature.ix  1H NMR (300 MHz, CDCl3, ppm): δ 5.85-5.98 (m, 1H), 5.55 (qq, J = 6.6, 1.1 Hz,
2H), 5.22-5.29 (m, 1H), 5.10-5.15 (m, 1H), 3.94 (br s, 1H), 3.85 (dq, J = 5.5, 0.8 Hz, 2H), 1.63
(dq, J = 6.6, 1.1 Hz, 6H), 1.46 (d, J = 1.1 Hz, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 135.6,
134.2, 121.2, 116.3, 88.3, 68.8, 13.3, 12.3.  HRMS (EI) m/z calc. for C12H20O: 180.15142, found
180.15135.
O O OH O O O
1. 9-BBN
2. NaOH/H2O2
THF, rt to 50 °C
(COCl)2
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Et3N
CH2Cl2
–78 °C to rt
[Ph3PMe]Br
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(2E,5E)-4-(But-3-enyloxy)-3,5-dimethylhepta-2,5-diene (15).  11 (1.07 g, 5.90 mmol) in 3.6
mL THF was added to a solution of  9-BBN (0.5M in THF, 14.2 mL, 7.12 mmol), and the
solution stirred at rt.  After 5 h 3.6 mL ethanol was added, followed by 1.4 mL 6M NaOHaq and
                                                 
ix La, D. S.; Alexander, J. B.; Cefalo, D. R.; Graf, D. D.; Hoveyda, A. H.; Schrock, R. R. J. Am.
Chem. Soc. 1998, 120, 9720–9721.
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2.8 mL 30% H2O2, and the reaction stirred at 50 °C for 1 h.  It was diluted with 20 mL sat’d
aqueous NaHCO3 and was extracted with ether (3×25 mL).  The organic layers were combined,
washed with brine, dried over Na2SO4, evaporated to an oil, and purified by flash
chromatography (20% EtOAc in hexanes) to give 916 mg (83%) of a colorless oil.  1H NMR
(300 MHz, CDCl3, ppm): δ 5.51 (qquint, J = 6.9 Hz, 1.1 Hz, 2H), 3.89 (br s, 1H), 3.79 (t, J = 5.2
Hz, 2H), 3.50 (t, J = 5.5 Hz, 2H), 2.62 (br s, 1H), 1.84 (quint, J = 5.8 Hz, 2H), 1.64 (dt, J = 6.6
Hz, 1.1 Hz, 6H), 1.46 (t, J = 1.4 Hz, 6H).   DMSO (0.89 mL, 12.6 mmol) was added slowly to a
solution of oxalyl chloride (0.66 mL, 7.56 mmol) in 15 mL CH2Cl2 at -78 °C.  After 5 min a
solution of the alcohol prepared above (500 mg, 2.52 mmol) in 5 mL CH2Cl2 was added to the -
78 °C reaction solution, and it stirred for 30 min.  Triethylamine (2.5 mL, 17.6 mmol) was
added, and after 30 min at - 78 °C, the reaction slowly warmed to rt.  It was quenched with 40
mL water and extracted with ether (3×50 mL).  The organic layers were combined, dried over
Na2SO4, and evaporated to 448 mg of an orange oil, which was used in the next step without
further purification (attempts to purify this aldehyde by silica gel chromatography resulted in
product decomposition and low (~30%) isolated yields).  To a suspension of
triphenylmethylphosphonium bromide (2.15 g, 6.0 mmol) in 20 mL THF at 0 °C was added n-
butyllithium (2.5 M in hexanes, 2.0 mL, 5.0 mmol).  After 20 min a solution of the crude
aldehyde (448 mg, 2.3 mmol) in 5 mL THF was added slowly to the orange reaction mixture,
and it stirred at 0 °C for 1 h.  It was quenched with 30 mL saturated aqueous NH4Cl and
extracted with ether (3×25 mL).  The organic layers were combined, dried over MgSO4, and
evaporated to an oil, which was purified by flash chromatography (1% EtOAc in hexanes) to
give 179 mg of a colorless oil.  To a solution of the oil in 10 mL CH2Cl2 was added 3% hydrogen
peroxide, and the mixture was shaken for 15 minutes.  The organic layer was removed, dried
over Na2SO4, evaporated to an oil, and filtered through a plug of silica gel (1% EtOAc in
S17
hexanes).  The filtrate was concentrated to 145 mg (29% over 2 steps) of 15 as a colorless oil.
1H NMR (300 MHz, CDCl3, ppm): δ 5.77-5.92 (m, 1H), 5.53 (qquint, J = 6.9, 1.4 Hz, 2H), 4.98-
5.11 (m, 2H), 3.88 (s, 1H), 3.33 (t, J = 6.9 Hz, 2H), 2.33 (q, J = 6.9 Hz, 2H), 1.63 (d, J = 6.6 Hz,
6H), 1.46 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 136.0, 134.5, 121.0, 116.2, 89.1, 67.6,
34.7, 13.3, 12.3.  HRMS (EI) m/z calc. for C13H22O: 194.1671, found 194.1679.
OH O
THF, reflux
NaH
Br
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(2E,5E)-3,5-Dimethyl-4-(pent-4-enyloxy)hepta-2,5-diene (17).  29 (400 mg, 2.9 mmol) was
added slowly to a suspension of NaH (60% in oil, 140 mg, 3.4 mmol) in 5 mL THF at rt, and
some bubbling occurred.  After 2.5 h at rt, 5-bromo-1-pentene (0.68 mL, 5.7 mmol) was added,
and the mixture was heated to reflux for 16 h.  It was cooled to rt, carefully quenched with 20
mL water, and extracted with ether (3×25 mL).  The organic layers were combined, washed with
brine, dried over Na2SO4, and evaporated to an oil, which was purified by flash chromatography
(1% EtOAc in hexanes, then 10% EtOAc in hexanes) to give 130 mg (22%) 17 as a colorless oil.
1H NMR (300 MHz, CDCl3, ppm): δ 5.76-5.90 (m, 1H), 5.53 (qquint, J = 6.6, 1.4 Hz, 2H), 4.92-
5.04 (m, 2H), 3.86 (s, 1H), 3.29 (t, J = 6.6 Hz, 2H), 2.13 (q, J = 6.9 Hz, 2H), 1.63-1.71 (m, 2H),
1.63 (d, J = 6.6 Hz, 6H), 1.46 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 138.9, 134.6, 120.9,
114.6, 89.1, 67.5, 30.8, 29.4, 13.4, 12.3. HRMS (EI) m/z calc. for C14H24O: 208.1827, found
208.1828.
OH O
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(2E,5E)-4-(Hex-5-enyloxy)-3,5-dimethylhepta-2,5-diene (19).  29 (500 mg, 3.6 mmol) was
added slowly to a suspension of NaH (60% in oil, 285 mg, 7.1 mmol) in 7 mL THF at rt, and
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some bubbling occurred.  After 15 min at rt, 6-bromo-1-hexene (0.96 mL, 7.1 mmol) was added,
the mixture was heated to reflux for 16 h.  It was cooled to rt, carefully quenched with 20 mL
sat’d aqueous NH4Cl, and extracted with ether (3×25 mL).  The organic layers were combined,
washed with brine, dried over MgSO4, and evaporated to an oil, which was purified by flash
chromatography (2% EtOAc in hexanes) to give 346 mg (44%) 19 as a colorless oil.  1H NMR
(300 MHz, CDCl3, ppm): δ 5.74-5.88 (m, 1H), 5.53 (qt, J = 6.6, 1.1 Hz, 2H), 4.91-5.03 (m, 2H),
3.85 (s, 1H), 3.27 (t, J = 6.4 Hz, 2H), 2.06 (q, J = 7.1 Hz, 2H), 1.63 (d, J = 6.9 Hz, 6H), 1.54-1.60
(m, 2H), 1.40-1.52 (m, 2H), 1.45 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 139.2, 134.6,
120.9, 114.5, 89.1, 67.9, 33.9, 29.6, 25.9, 13.3, 12.3.  HRMS (EI) m/z calc. for C15H26O:
222.1984, found 222.1971.
OH O Si
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Allyl((2E,5E)-3,5-dimethylhepta-2,5-dien-4-yloxy)dimethylsilane (13).
Allylchlorodimethylsilane (1.1 mL, 7.5 mmol) was added to a solution of 29 (1.0 g, 7.1 mmol),
triethylamine (1.2 mL, 8.6 mmol), and N,N-dimethylaminopyridine (44 mg, 0.4 mmol) in 30 mL
CH2Cl2 at rt.  After 5 h the reaction was quenched with 50 mL water, the organic layer was
removed, and the aqueous layer was extracted with ether (3×50 mL).  The organic layers were
combined, washed with brine, dried over Na2SO4, and evaporated to an oil.  The oil was
redissolved in hexanes and was filtered through a pad of neutral alumina.  The filtrate was
condensed to give 1.30 g (76%) 13 as a colorless oil.  Attempts to purify 13 by silica gel
chromatography resulted in inconsistent yields and varying levels of purity due to product
decomposition.  1H NMR (300 MHz, CDCl3, ppm): δ 5.70-5.85 (m, 1H), 5.52 (qquint, J = 6.9,
1.4 Hz, 2H), 4.80-4.90 (m, 2H), 4.30 (s, 1H), 1.61 (dt, J = 6.9, 1.1 Hz, 6H), 1.58-1.63 (m, 2H),
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1.43 (t, J = 1.1 Hz, 6H), 0.08 (s, 6H).  13C NMR (75 MHz, CDCl3, ppm): δ 136.4, 134.8, 119.9,
113.5, 82.4, 25.1, 13.3, 12.0, –1.9.  HRMS (EI) m/z calc. for C14H26OSi: 238.1753, found
238.1752.
OH O Si
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Allyl(((2E,5E)-3,5-dimethylhepta-2,5-dien-4-yloxy)methyl)dimethylsilane (21).  29 (300 mg,
2.1 mmol) was added to a suspension of NaH (60% in oil, 103 mg, 2.6 mmol) in 3 mL THF and
some bubbling occurred.  After 30 min at rt, allylchloromethyldimethylsilane (0.70 mL, 4.3
mmol) was added, and the mixture was heated to reflux for 16 h.  The reaction mixture was
cooled to rt, quenched with 20 mL water, and extracted with ether (3×20 mL).  The organic
layers were combined, washed with brine, dried over MgSO4, and evaporated to a yellow oil,
which was purified by flash chromatography (100% hexanes) to give 349 mg (65%) 21 as a
colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.81-5.95 (m, 1H), 5.51 (qquint, J = 6.6, 1.4
Hz, 2H), 4.98 (dq, J = 17.1, 1.7 Hz, 1H), 4.85-4.91 (m, 1H), 4.28 (s, 1H), 2.03-2.12 (m, 2H),
1.61 (dt, J = 6.9, 1.1 Hz, 6H), 1.43 (t, J = 1.1 Hz, 6H), 0.64-0.70 (m, 2H), 0.07 (s, 6H).  13C NMR
(75 MHz, CDCl3, ppm): δ 142.0, 136.5, 119.8, 112.8, 82.3, 27.6, 16.2, 13.3, 12.1, –1.4.  HRMS
(FAB) m/z calc. for C15H28OSi: 252.1910, found 252.1914.
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30
(2E,7E)-3,7-Dimethylnona-2,7-dien-5-ol (30).  Titanocene dichloride (212 mg, 0.85 mmol) was
added to a solution of 2-butyne (2.4 mL, 30 mmol) and isobutylmagnesium bromide (2.0 M in
S20
diethyl ether, 15 mL, 30 mmol) in 30 mL Et2O, and the solution stirred at rt for 1 h.  This brown
solution was slowly transferred via syringe to a suspension of CuBr (397 mg, 2.8 mmol) in Et2O
(75 mL) at –78 °C.  After 5 min epichlorohydrin (2.2 mL, 28 mmol) was added slowly to the
mixture.  It stirred at –78 °C for 3 h, and was allowed to warm to –40 °C where it continued
stirring for 48 h.  The reaction mixture was poured into 100 mL 1 N HCl(aq) and was extracted
with ether (3×100 mL).  The organic layers were combined, dried over MgSO4, and evaporated
to an oil, which was purified by flash chromatography (10% EtOAc in hexanes) to give 2.83 g of
the chlorohydrin as a yellow oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.36 (qq, J = 6.6, 1.1 Hz,
1H), 3.89-3.97 (m, 1H), 3.61 (dd, J = 11.0, 4.1 Hz , 1H), 3.50 (dd, J = 11.0, 6.3 Hz, 1H), 2.29
(dd, J = 13.5, 5.5 Hz, 1H), 2.20 (dd, J = 13.5, 8.0 Hz, 1H), 2.04 (br s, 1H), 1.66 (t, J = 1.1 Hz,
3H), 1.62 (dt, J = 6.9 Hz, 0.8 Hz, 3H).  The chlorohydrin (2.8 g, 19 mmol) was added slowly to a
suspension of NaH (60% in oil, 1.13 g, 28 mmol) in 50 mL THF, and the mixture stirred at
reflux for 16 h.  It was cooled to rt, quenched with sat’d aqueous NH4Cl until pH = 9 was
reached, and was extracted with ether (3×50 mL).  The organic layers were combined, dried over
MgSO4, and evaporated to a yellow oil, which was purified by flash chromatography (1% Et2O
in pentane) to give 1.08 g of the epoxide as a pale yellow oil.  1H NMR (300 MHz, CDCl3, ppm):
δ 5.34 (qq, J = 6.6, 1.1 Hz, 1H), 2.96-3.02 (m, 1H), 2.77 (dd, J = 4.9, 3.8 Hz, 1H), 2.49 (dd, J =
4.9, 2.7 Hz, 1H), 2.25 (dd, J = 14.8, 6.0 Hz, 1H), 2.16 (dd, J = 14.5, 5.5 Hz, 1H), 1.69 (t, J = 1.1
Hz, 3H), 1.61 (dq, J = 6.6, 1.1 Hz, 3H).  Titanocene dichloride (69 mg, 0.28 mmol) was added to
a solution of 2-butyne (0.8 mL, 10 mmol) and isobutylmagnesium bromide (2.0 M in diethyl
ether, 4.9 mL, 10 mmol) in 10 mL Et2O, and the solution stirred at rt for 1 h.  This brown
solution was slowly transferred via syringe to a suspension of CuBr (128 mg, 0.9 mmol) in Et2O
(25 mL) at –78 °C.  After 5 min the epoxide (1.0 g, 9 mmol) was added slowly to the mixture.  It
stirred at –78 °C for 2 h, and was allowed to warm to –40 °C where it continued stirring for 24 h.
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The reaction mixture was poured into 75 mL 1 N HCl(aq) and was extracted with ether (3×50
mL).  The organic layers were combined, dried over Na2SO4, and evaporated to an oil, which
was purified by flash chromatography (7% EtOAc in hexanes) to give 894 mg (21% over 3
steps) of 30 as a pale yellow oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.30 (q, J = 6.6 Hz, 2H),
3.75-3.82 (m, 1H), 2.01-2.15 (m, 4H), 1.79 (d, J = 1.7 Hz, 1H), 1.62 (s, 6H), 1.59 (d, J = 6.6 Hz,
6H).  13C NMR (75 MHz, CDCl3, ppm): δ 133.0, 122.2, 66.6, 47.7, 16.0, 13.7.  HRMS (EI) m/z
calc. for C11H20O: 168.1514, found 168.1515.
OH
30
CH2Cl2, rt
Cl Si
Et3N
DMAP O
Si
23
Allyl((2E,7E)-3,7-dimethylnona-2,7-dien-5-yloxy)dimethylsilane (23).  To a solution of 30
(150 mg, 0.9 mmol), triethylamine (0.25 mL, 1.8 mmol), and N,N-dimethylaminopyridine (5 mg,
0.04 mmol) in 5 mL CH2Cl2 was added allylchlorodimethylsilane (0.20 mL, 1.3 mmol).  After
stirring at rt for 16 h, the reaction was quenched with 10 mL water and extracted with ether
(3×20 mL).  The organic layers were combined, washed with brine, dried over Na2SO4, and
evaporated to an oil, which was purified by flash chromatography (1% EtOAc in hexanes) to
give 209 mg (88%) of 23 as a colorless oil.  1H NMR (300 MHz, CDCl3, ppm): δ 5.70-5.84 (m,
1H), 5.23 (qq, J = 6.6, 1.4 Hz, 2H), 4.81-4.89 (m, 2H), 3.85 (quint, J = 6.3 Hz, 1H), 2.05-2.08
(m, 4H), 1.60 (t, J = 1.1 Hz, 6H), 1.58 (dt, J = 6.6, 0.8 Hz, 6H), 1.54-1.57 (m, 2H), 0.05 (s, 6H).
13C NMR (75 MHz, CDCl3, ppm): δ 134.7, 133.0, 121.7, 113.5, 70.5, 48.2, 25.4, 16.5, 13.6, –1.7.
HRMS (EI) m/z calc. for C16H30OSi: 266.2066, found 266.2070.
General Procedure A:  Asymmetric Ring-Closing Reactions with 2a-5a.  Triene was added to
a solution of dichloride catalyst (1-2 mol %) in CH2Cl2 (0.055 M), and the reaction stirred at 40
S22
°C for 2 h.  The solvent was evaporated, and the remaining residue was purified by flash
chromatography to yield the desired cyclic diene.
General Procedure B:  Asymmetric Ring-Closing Reactions with 2b-5b.  A solution of NaI
(25 equiv. relative to catalyst) and dichloride catalyst (4 mol %) in THF were stirred at rt for 1 h.
Triene (0.055 M) was added, and the solution stirred at 40 °C for 2 h.  The solvent was
evaporated, and the remaining residue was purified by flash chromatography to yield the desired
cyclic diene.
O
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2b (4 mol %)
THF, 40 °C
O
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(S,E)-2-(But-2-en-2-yl)-3-methyl-2,5-dihydrofuran (12).  Following general procedure B, 11
(40 mg, 0.22 mmol), 2a (8.9 mg, 0.0089 mmol), and NaI (33 mg, 0.22 mmol) in 4 mL THF gave
19.8 mg (64%) of 12 as a pale yellow oil (5% Et2O in pentane) in 90% ee.  [α]D25 = +116.5
(CHCl3, c = 0.55).  1H NMR (300 MHz, CDCl3, ppm): δ 5.56 (quint, J = 1.6 Hz, 1H), 5.52 (q, J =
6.9 Hz, 1H), 4.88 (br s, 1H), 4.53-4.68 (m, 2H), 1.64 (dq, J = 6.9, 1.1 Hz, 3H), 1.56 (quint, J =
1.4 Hz, 3H), 1.47 (quint, J = 1.4 Hz, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 137.2, 135.6,
123.8, 121.5, 95.0, 75.6, 13.5, 12.4, 10.1.  HRMS (EI) m/z calc. for C9H14O: 138.1045, found
138.1040.
2b (4 mol %)
THF, 40 °C
O
15
O
16
(S,E)-6-(But-2-en-2-yl)-5-methyl-3,6-dihydro-2H-pyran (16).  Following general procedure B,
15 (40 mg, 0.21 mmol), 2a (8.2 mg, 0.0082 mmol), and NaI (31 mg, 0.21 mmol) in 3.8 mL THF
gave 22.7 mg (73%) of 16 as a pale yellow oil (3% Et2O in pentane) in 90% ee.  [α]D26 = +43.0
S23
(CHCl3, c = 0.69).  1H NMR (300 MHz, CDCl3, ppm): δ 5.64-5.68 (m, 1H), 5.53 (q, J = 6.6 Hz,
1H), 4.29 (s, 1H), 3.88-3.94 (m, 1H), 3.53-3.61 (m, 1H), 2.19-2.32 (m, 1H), 1.85-1.96 (m, 1H),
1.64 (dd, J = 6.6, 1.1 Hz, 3H), 1.54 (t, J = 1.4 Hz, 3H), 1.47 (q, J = 1.4 Hz, 3H).  13C NMR (75
MHz, CDCl3, ppm): δ 134.9, 134.5, 125.2, 121.5, 84.1, 62.9, 25.8, 19.7, 13.5, 11.5.  HRMS (EI)
m/z calc. for C10H16O: 152.1201, found 152.1204.
2a (2 mol %)
CH2Cl2, 40 °C
O
17 18
O
(S,Z)-7-((E)-But-2-en-2-yl)-6-methyl-2,3,4,7-tetrahydrooxepine (18).  Following a modified
version of general procedure A, 17 (40 mg, 0.19 mmol) was added to a solution of 5a (2.1 mg,
0.0019 mmol) in 3.5 mL CH2Cl2, and the reaction stirred at 40 °C.  After 2 h, an additional
portion of 5a (2.1 mg, 0.0019 mmol) was added, and the solution stirred at 40 °C for an
additional 2 h.  The solvent was removed by evaporation, and the residue was purified by flash
chromatography (4% EtOAc in hexanes) to give 29.4 mg (92%) of 18 as a yellow oil in 76% ee.
[α]D24 = +164.0 (CHCl3, c = 0.90).  1H NMR (300 MHz, CDCl3, ppm): δ 5.57-5.62 (m, 1H), 5.51
(q, J = 6.6 Hz, 1H), 4.26 (s, 1H), 3.85-3.92 (m, 1H), 3.57-3.66 (m, 1H), 2.48-2.59 (m, 1H), 1.87-
2.03 (m, 2H), 1.67-1.80 (m, 1H), 1.67 (t, J = 2.2 Hz, 3H), 1.65 (d, J = 6.6 Hz, 3H), 1.50 (s, 3H).
13C NMR (75 MHz, CDCl3, ppm): δ 137.2, 134.6, 125.3, 124.0, 91.4, 66.3, 29.2, 23.4, 21.9, 13.5,
12.5.  HRMS (EI) m/z calc. for C11H18O: 166.1358, found 166.1353.
O Si
13
2a (0.8 mol %)
CH2Cl2, 40 °C
O
Si
14
(S,E)-6-(But-2-en-2-yl)-2,2,5-trimethyl-3,6-dihydro-2H-1,2-oxasiline (14).  Following general
procedure A, 13 (0.95 g, 4.0 mmol) and 5a (35 mg, 0.032 mmol) in 72 mL CH2Cl2 gave 0.60 g
(77%) of 14 as a yellow oil (3% EtOAc in hexanes) in 92% ee.  [α]D25 = +195.4 (CHCl3, c =
S24
0.96).  1H NMR (300 MHz, CDCl3, ppm): δ 5.69 (dquint, J = 7.7, 1.4 Hz, 1H), 5.49 (q, J = 6.6
Hz, 1H), 4.54 (s, 1H), 1.63 (dd, J = 6.6, 1.1 Hz, 3H), 1.54 (t, J = 1.1 Hz, 3H), 1.51 (s, 3H), 1.29-
1.39 (m, 1H), 1.12-1.21 (m, 1H), 0.19 (s, 3H), 0.13 (s, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ
136.9, 136.0, 122.9, 120.4, 83.4, 22.0, 13.5, 12.5, 10.7, 0.3, –0.6.  HRMS (EI) m/z calc. for
C11H20OSi: 196.1284, found 196.1281.
2a (1 mol %)
CH2Cl2, 40 °C
O Si
21
SiO
22
(S,Z)-7-((E)-But-2-en-2-yl)-3,3,6-trimethyl-2,3,4,7-tetrahydro-1,3-oxasilepine (22).
Following general procedure A, 21 (40 mg, 0.16 mmol) and 5a (1.7 mg, 0.0016 mmol) in 2.9 mL
CH2Cl2 gave 21.7 mg (65%) of 22 as a yellow oil (2% EtOAc in hexanes) in 92% ee.  [α]D25 =
+184.3 (CHCl3, c = 0.75).  1H NMR (300 MHz, CDCl3, ppm): δ 5.66 (t, J = 7.4 Hz, 1H), 5.49 (q,
J = 6.9 Hz, 1H), 4.49 (s, 1H), 2.55-2.67 (m, 1H), 2.02-2.12 (m, 1H), 1.68 (t, J = 1.1 Hz, 3H), 1.64
(d, J = 6.9 Hz, 3H), 1.56 (s, 3H), 0.75-0.86 (m, 2H), 0.16 (s, 3H), 0.14 (s, 3H).  13C NMR (75
MHz, CDCl3, ppm): δ 137.2, 136.5, 128.8, 121.8, 84.0, 22.6, 21.9, 16.8, 13.5, 11.8, 0.9, –0.3.
HRMS (EI) m/z calc. for C12H22OSi: 210.1440, found 210.1449.
O
Si
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2b (4 mol %)
THF, 40 °C
Si
O
24
(S,Z)-2,2,5-Trimethyl-7-((E)-2-methylbut-2-enyl)-2,3,6,7-tetrahydro-1,2-oxasilepine (24).
Following general procedure B, 23 (40 mg, 0.15 mmol), 2a (6.0 mg, 0.006 mmol), and NaI (23
mg, 0.15 mmol) in 2.7 mL THF gave 33.1 mg (98%) of 24 as a light yellow oil (2% EtOAc in
hexanes) in 78% ee.  [α]D24 = +8.3 (CHCl3, c = 0.99).  1H NMR (300 MHz, CDCl3, ppm): δ 5.53
(t, J = 7.4 Hz, 1H), 5.24 (qq, J = 6.6, 1.1 Hz, 1H), 3.97-4.05 (m, 1H), 2.21-2.36 (m, 2H), 2.01-
2.10 (m, 2H), 1.70 (s, 3H), 1.62 (s, 3H), 1.59 (d, J = 6.6 Hz, 3H), 1.54-1.60 (m, 1H), 1.31-1.39
S25
(m, 1H), 0.11 (s, 3H), 0.08 (s, 3H).  13C NMR (75 MHz, CDCl3, ppm): δ 134.3, 133.4, 121.3,
121.2, 71.1, 49.2, 41.3, 25.9, 18.0, 16.2, 13.6, 0.4, –1.4.  HRMS (EI) m/z calc. for C13H24OSi:
224.1597, found 224.1598.
Absolute Stereochemistry Determination.  The absolute stereochemistry of 28 has been
previously proven.ix  Compound 12 was transformed into 28 by ethylenolysis, and the chiral GC
trace (Chiraldex G-TA, same column used in ref. ix) showed that it was the opposite absolute
stereochemistry of that which was proven.  Additionally, that same experiment proved the
absolute stereochemistry of 12.  The absolute stereochemistry of 14 was determined by oxidizing
it to the diol and subsequent mesylation/intramolecular nucleophilic substitution gave 12.  12
synthesized from 14 had the same absolute stereochemistry as the 12 synthesized by asymmetric
ring-closing metathesis.  For any given ring-closing substrate in this paper, catalysts 2a through
5b all gave products with the same absolute stereochemistry.
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